Product Image

Vanish LCarnitine 3000 Berry

PS ProSupps
4.6
★ ★ ★ ★ ★
(5997 ratings)
L-Carnitine 3000 mg
Product Image
Score76
A focused unspecified L-carnitine serving with excellent stated cost efficiency. The chemical form and branded purity source are missing is the main quality limitation.
How scoring works
Quantity:16 Fluid Ounce(s) • (31 servings)
Goals:
Fitness
Cardiovascular Support

Score 76

A focused unspecified L-carnitine serving with excellent stated cost efficiency. The chemical form and branded purity source are missing is the main quality limitation.
How scoring works
$22.99($0.74 per serving)
BodyBuilding.com
$ 29.99
Supplement City
$ 22.99
iHerb
$ 29.99
BodyBuilding.com
$ 29.99
Amazon
$ 29.99
Report prices

Analysis

3,000 mg of unspecified L-carnitine forms the core of the serving. The ingredient may support exercise or cardiovascular needs when carnitine support is relevant, but it is not a direct fat-loss shortcut.

The formula is best aligned with fitness and cardiovascular support. Benefits for energy or cognition depend on the specific form and the user’s baseline status.

The amount is clearly listed and excellent stated cost efficiency supports practical use. The chemical form and branded purity source are missing prevents a stronger judgment of elemental yield, purity, and form-specific fit.

Who is it for
  • Adults seeking focused carnitine supplementation
  • People interested in fitness and cardiovascular support
  • Users who tolerate carnitine
Best for
  • Carnitine supplementation
  • Exercise-related support
  • Cardiovascular nutrient support

Pros

  • Clearly states the carnitine amount
  • Provides 3,000 mg
  • Keeps the formula focused

Cons

  • The chemical form and branded purity source are missing
  • Benefits depend on individual need
  • Serving is aggressive

Warnings

  • The 3,000 mg serving may cause nausea, diarrhea, cramps, or a fishy body odor.
  • Carnitine can interact with warfarin and may require closer anticoagulation monitoring.
  • People with seizure disorders should review carnitine use because it may worsen seizure risk in susceptible users.

Nutrient quality

74 High impact

A substantial carnitine amount provides focused metabolic and fitness support. Missing chemical-form and yield details limit ingredient quality confidence.

.

Ingredient transparency

75 High impact

Active amounts are clearly shown without a hidden blend. Carnitine form, complete directions, and inactive liquid ingredients remain undisclosed.

.

Customer satisfaction

68 High impact

The supplied aggregate satisfaction signal is favorable and has some support from its response volume. Specific experience details are absent, so complaint patterns and purpose fit cannot be confirmed.

.

Value for money

87 Highest impact

A focused high-dose carnitine formula and attractive serving value support good value. Incomplete form detail is the main limitation.

.
Report analysis

Goals

Fitness
Impact
High effect
B Goal FitC Strength of SupportC- CoverageA Formula Quality

L-carnitine may support fatty-acid transport and exercise recovery, but its performance effect is less direct than creatine. Human evidence suggests possible soreness and recovery benefits, though results for fat loss and general performance are mixed.

The stated amount is substantial but sits above the preferred range. The chemical form and elemental yield are not disclosed, which sharply limits quality confidence.

Study evidence
L-Carnitine Supportive 52 studies
Cardiovascular Support
Impact
High effect
B- Goal FitC Strength of SupportC- CoverageA- Formula Quality
L-Carnitine · 3000 mg

A large L-carnitine amount supports fatty-acid transport for heart-muscle energy production. The dose gives the product meaningful depth in a cardiac-energy pathway.

The serving exceeds the preferred range used here, while the chemical form and elemental yield are not disclosed. Added pantothenic acid has a plausible energy-metabolism role but does not resolve the main quality uncertainty.

Study evidence
L-Carnitine Supportive 73 studies

Ingredients

IngredientAmount per serving
Calories
0 Calorie(s)
Total Carbohydrate
0 Gram(s)
Pantothenic Acid
10 mg
L-Carnitine
3000 mg
Gluten Free Adults 18–50 Sugar Free Women
Report overview
L-Carnitine · 3000 mg OverallScore42
F Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyA+ Value

The stated 3000 mg amount is above the preferred range but does not exceed the rubric's high-dose penalty threshold. No chemical form or branded purity source is supplied, so actual yield and material quality remain uncertain. Calculated cost efficiency is excellent if the full listed amount is elemental L-carnitine.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials.
    Askarpour M; Hadi A; Symonds ME; Miraghajani M; Omid Sadeghi; Sheikhi A; Ghaedi E · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2020
    Meta-analysis55 studies pooledCardiovascular Support forL-Carnitine
  2. Efficacy of a novel formulation of L-Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study.
    Evans M; Guthrie N; Pezzullo J; Sanli T; Fielding RA; Bellamine A · Nutrition & metabolism · 2020
    Randomized trial42 participantsFitness forL-Carnitine
  3. Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial.
    Parvanova A; Trillini M; Podestà MA; Iliev IP; Aparicio C; Perna A; Peraro F; Rubis N; Gaspari F; Cannata A; Ferrari S; Bossi AC; Trevisan R; Parameswaran S; Chávez-Iñiguez JS; Masnic F; Seck SM; Jiamjariyaporn T; Cortinovis M; Perico L; Sharma K; Remuzzi G; Ruggenenti P; Warnock DG · Journal of the Endocrine Society · 2022
    Randomized trial229 participantsCardiovascular Support forL-Carnitine
  4. Acute L-Carnitine Supplementation Does Not Improve CrossFit® Performance: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
    Devrim-Lanpir A; Velasco LS; Ramirez Lara FG; Ojeda Sanchez A; Kimble R; Zare R; Gunes FE; Knechtle B; Weiss K; Rosemann T; Heinrich K · Nutrients · 2025
    Randomized trial20 participantsFitness forL-Carnitine
  5. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.
    Koeth RA; Wang Z; Levison BS; Buffa JA; Org E; Sheehy BT; Britt EB; Fu X; Wu Y; Li L; Smith JD; DiDonato JA; Chen J; Li H; Wu GD; Lewis JD; Warrier M; Brown JM; Krauss RM; Tang WH; Bushman FD; Lusis AJ; Hazen SL · Nature medicine · 2013
    Other2,595 participantsCardiovascular Support forL-Carnitine
  6. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial.
    Malaguarnera M; Cammalleri L; Gargante MP; Vacante M; Colonna V; Motta M · The American journal of clinical nutrition · 2008
    Randomized trial66 participantsFitness forL-Carnitine
  7. The Effects of L-Carnitine Supplementation on Weight Loss, Glycemic Control, and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Systematic Review and Dose-response Meta-Analysis of Randomized Controlled Trials.
    Mirrafiei A; Jayedi A; Shab-Bidar S · Clinical therapeutics · 2024
    Meta-analysis2,041 participants21 studies pooledCardiovascular Support forL-Carnitine
  8. A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.
    Brass EP; Koster D; Hiatt WR; Amato A · Vascular medicine (London, England) · 2013
    Meta-analysis13 studies pooledFitness forL-Carnitine
  9. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes.
    Malaguarnera M; Vacante M; Avitabile T; Malaguarnera M; Cammalleri L; Motta M · The American journal of clinical nutrition · 2009
    Randomized trial81 participantsCardiovascular Support forL-Carnitine
  10. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsFitness forL-Carnitine
  11. L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Choi M; Park S; Lee M · Nutrients · 2021
    Meta-analysis9 studies pooledCardiovascular Support forL-Carnitine
  12. Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans.
    Wall BT; Stephens FB; Constantin-Teodosiu D; Marimuthu K; Macdonald IA; Greenhaff PL · The Journal of physiology · 2012
    Randomized trial14 participantsFitness forL-Carnitine
  13. Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis.
    Shang R; Sun Z; Li H · BMC cardiovascular disorders · 2015
    Meta-analysis3,108 participants5 studies pooledCardiovascular Support forL-Carnitine
  14. Effects of nine weeks L-Carnitine supplementation on exercise performance, anaerobic power, and exercise-induced oxidative stress in resistance-trained males.
    Koozehchian MS; Daneshfar A; Fallah E; Agha-Alinejad H; Samadi M; Kaviani M; Kaveh B M; Jung YP; Sablouei MH; Moradi N; Earnest CP; Chandler TJ; Kreider RB · Journal of exercise nutrition & biochemistry · 2020
    Randomized trial23 participantsFitness forL-Carnitine
  15. The Effects of L-Carnitine Supplementation on Serum Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Fathizadeh H; Milajerdi A; Reiner Ž; Kolahdooz F; Chamani M; Amirani E; Asemi Z · Current pharmaceutical design · 2020
    Meta-analysis67 studies pooledCardiovascular Support forL-Carnitine
  16. Propionyl-L-carnitine for intermittent claudication.
    Kamoen V; Vander Stichele R; Campens L; De Bacquer D; Van Bortel L; de Backer TL · The Cochrane database of systematic reviews · 2022
    Meta-analysis1,423 participants12 studies pooledFitness forL-Carnitine
  17. The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia.
    Shahidi M; Hashemi SR; Fattahi N; Roshani D; Vahedi S; Sharifi P; Moradveisi B · Journal of pediatric hematology/oncology · 2020
    Randomized trial60 participantsCardiovascular Support forL-Carnitine
  18. Prolonged oral L-carnitine substitution increases bicycle ergometer performance in patients with severe, ischemically induced cardiac insufficiency.
    Löster H; Miehe K; Punzel M; Stiller O; Pankau H; Schauer J · Cardiovascular drugs and therapy · 2000
    Randomized trial41 participantsFitness forL-Carnitine
  19. Associations of circulating choline and its related metabolites with cardiometabolic biomarkers: an international pooled analysis.
    Pan XF; Yang JJ; Shu XO; Moore SC; Palmer ND; Guasch-Ferré M; Herrington DM; Harada S; Eliassen H; Wang TJ; Gerszten RE; Albanes D; Tzoulaki I; Karaman I; Elliott P; Zhu H; Wagenknecht LE; Zheng W; Cai H; Cai Q; Matthews CE; Menni C; Meyer KA; Lipworth LP; Ose J; Fornage M; Ulrich CM; Yu D · The American journal of clinical nutrition · 2021
    Meta-analysis32,853 participants17 studies pooledCardiovascular Support forL-Carnitine
  20. L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs.
    Borghi-Silva A; Baldissera V; Sampaio LM; Pires-DiLorenzo VA; Jamami M; Demonte A; Marchini JS; Costa D · Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2007
    Randomized trial16 participantsFitness forL-Carnitine
  21. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F · Atherosclerosis · 2007
    Randomized trial52 participantsCardiovascular Support forL-Carnitine